Nu Skin Enterprises Stock Current Liabilities
| NUS Stock | USD 7.55 0.33 4.57% |
Nu Skin Enterprises fundamentals help investors to digest information that contributes to Nu Skin's financial success or failures. It also enables traders to predict the movement of NUS Stock. The fundamental analysis module provides a way to measure Nu Skin's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nu Skin stock.
Non Current Liabilities Total is likely to gain to about 688.4 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 305 M in 2024. NUS | Current Liabilities |
Nu Skin Enterprises Company Current Liabilities Analysis
Nu Skin's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Nu Skin Current Liabilities | 407.6 M |
Most of Nu Skin's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nu Skin Enterprises is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
NUS Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Nu Skin is extremely important. It helps to project a fair market value of NUS Stock properly, considering its historical fundamentals such as Current Liabilities. Since Nu Skin's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nu Skin's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nu Skin's interrelated accounts and indicators.
Click cells to compare fundamentals
NUS Current Liabilities Historical Pattern
Today, most investors in Nu Skin Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nu Skin's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Nu Skin current liabilities as a starting point in their analysis.
Nu Skin Current Liabilities |
| Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
NUS Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Nu Skin Enterprises has a Current Liabilities of 407.6 M. This is 92.1% lower than that of the Personal Care Products sector and 88.23% lower than that of the Consumer Staples industry. The current liabilities for all United States stocks is 94.84% higher than that of the company.
NUS Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nu Skin's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nu Skin could also be used in its relative valuation, which is a method of valuing Nu Skin by comparing valuation metrics of similar companies.Nu Skin is currently under evaluation in current liabilities category among its peers.
Nu Skin ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nu Skin's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nu Skin's managers, analysts, and investors.Environmental | Governance | Social |
NUS Fundamentals
| Return On Equity | -0.13 | ||||
| Return On Asset | 0.0555 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 622.91 M | ||||
| Shares Outstanding | 49.71 M | ||||
| Shares Owned By Insiders | 2.29 % | ||||
| Shares Owned By Institutions | 81.10 % | ||||
| Number Of Shares Shorted | 1.56 M | ||||
| Price To Earning | 10.70 X | ||||
| Price To Book | 0.51 X | ||||
| Price To Sales | 0.20 X | ||||
| Revenue | 1.97 B | ||||
| Gross Profit | 1.59 B | ||||
| EBITDA | 137.66 M | ||||
| Net Income | 8.6 M | ||||
| Cash And Equivalents | 264.73 M | ||||
| Cash Per Share | 7.69 X | ||||
| Total Debt | 607.33 M | ||||
| Debt To Equity | 0.59 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 14.22 X | ||||
| Cash Flow From Operations | 118.64 M | ||||
| Short Ratio | 2.08 X | ||||
| Earnings Per Share | (2.09) X | ||||
| Price To Earnings To Growth | 2.35 X | ||||
| Target Price | 8.25 | ||||
| Number Of Employees | 3.7 K | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 358.91 M | ||||
| Total Asset | 1.81 B | ||||
| Retained Earnings | 1.87 B | ||||
| Working Capital | 373 M | ||||
| Current Asset | 706.39 M | ||||
| Current Liabilities | 407.6 M | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 3.09 % | ||||
| Net Asset | 1.81 B | ||||
| Last Dividend Paid | 0.57 |
About Nu Skin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nu Skin Enterprises's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nu Skin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nu Skin Enterprises based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.